From the other dimension of the correlation, KDR, CCL14, CXCL12, IL6R, TNFSF13, and CX3CR1 were negatively correlated with RAD51 in multiple cancer types, while LAG3, CD276, MICB, ULBP1, TAP1, and TAP2 were positively correlated with RAD51 in most cancer types, indicating that these molecules can be potential immunotherapy targets of RAD51 across cancer types. The gene discussed is TAP1; the disease is cancer.